CiteFacts · FDA Drug Shortages · FDA source
Penicillin G Benzathine Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Laboratorios Atral | Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01) | Available | 08/17/2026 |
| Pfizer Inc. | Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) | Limited Availability | 08/12/2026 |
| Pfizer Inc. | Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10) | Limited Availability | 08/12/2026 |
| Pfizer Inc. | Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10) | Unavailable | 08/12/2026 |
Source facts
Grouped generic ingredient: Penicillin G Benzathine Injection · 4 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Anti-Infective
Dosage forms: Injection
Routes: INTRAMUSCULAR
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.